Home [sandbox] K4D COVID-19 Resource Hub Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-06-30

Link:

https://api.zotero.org/groups/2494380/items/VSXD2BXM?format=atom

Updated:

06/30/2020, 17:04

From feeds:

[sandbox] K4D COVID-19 Resource Hub » Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items

Tags:

Authors:

jimwoodhill

Date tagged:

06/30/2020, 17:17

Date published:

06/30/2020, 16:45